Adenosine A1 receptor antagonist improves intradialytic hypotension

Kidney International

Volumn 69, Issue 5, 2006, Pages 877-883

  Imai, E ^a   Fujii, M ^b   Kohno, Y ^c   Kageyama, H ^c   Hori, M ^a   Tsubakihara, Y ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

A1 antagonist; Adenosine; Intradialytic hypotension

Indexed keywords

1 [3 (2 PHENYLPYRAZOLO[1,5 A]PYRIDIN 3 YL)ACRYLOYL]PIPERIDINE 2 ACETIC ACID; ADENOSINE A1 RECEPTOR ANTAGONIST; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EMERGENCY TREATMENT; FEMALE; HEART RATE; HEMODIALYSIS; HUMAN; HYPOTENSION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 33644544442     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000088     Document Type: Article

References (20)

1. USRDS. Background on the US ESRD program. Am J Kid Dis 2003; 41: S15-S28.
2. Daugirdas J. Preventing and managing hypotension. Semi Dial 1994; 7: 276-283.
3. Perazella M. Approach to patients with intradialytic hypotension: a focus on therapeutic options. Semi Dial 1999; 12: 175-181.
4. van der Sande F, Kooman J, Leunissen K. Strategies for improving homodynamic stability in cardiac-compromised dialysis patients. Am J Kid Dis 2000; 35: E19.
5. Koch M, Thomas B, Tschope W, Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993; 36: 1113-1117.
6. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney int 2004; 66: 1212-1220.
7. Daugirdas J. Dialysis hypotension: a hemodynamic analysis. Kidney Int 1991; 39: 233-246.
8. Barnas M, Boer W, Koomans H. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypertension. J Am Soc Nephrol 1999; 10: 2577-2584.
9. Kreppel H, Nette R, Akcaheuseyin E et al. Variability of relative blood volume during hemodialysis. Nephrol Dial Transplant 2000; 15; 673-679.
10. Maeda K, Morita H, Shinzato T. Role of hypovolemia in dialysis-induced hypotension. Artif Organ 1988; 12: 116-121.
11. Shinzato T, Miwa T, Nakai S et al. Role of adenosine in dialysis-induced hypotension. J Am Soc Nephrol 1994; 4: 1987-1994.
12. Guieu R, Brunet P, Sampol J et al. Adenosine and hemodialysis in humans. J Invest Med 2001; 49: 56-67.
13. Palmer T, Stiles G. Neurotransmitter receptors: VII. Adenosine receptors. Neuropharmacology 1995; 34: 683-694.
14. 35S]GTPrS binding studies. Eur J Pharmacol 1999; 365: 309-315.
15. Woolliscroft J, Fox I. Increased body fluid prine levels during hypotensive events. Am J Med 1986; 81: 472-478.
16. Takkanat K, Port F, Schmaltz S et al. Excessive ATP degradation during hemodialysis against sodium acetate. J Lab Clin Med 1988; 112: 686-693.
17. Snyder D, Wang W, Pelleg A et al. Effect of aging on A1-adenosine receptor-mediated inhibition of norepinephrine release in the rat heart. J Cardiovasc Pharmacol 1998; 31: 352-358.
18. Brown C, Collis M. Adenosine A1 receptor mediated inhibition of nerve stimulation-induced contractions of the rabbit portal vein. Eur J Pharmacol 1983; 93: 277-282.
19. Evans D, Schenden J, Bristol J. Adenosine receptor mediated cardiac depression. Life Sci 1982; 31: 2425.
20. Belhassen B, Llia R, Greenspan AM et al. Autonomic modulation of aminophylline influence on the electrophysiologic effects of adenosine and adenosine triphosphate in the canine heart. Cardiovasc Res 1987; 21: 151.